Vaxcyte Inc

NASDAQ:PCVX   4:00:00 PM EDT
43.22
-1.11 (-2.50%)
4:41:26 PM EDT: $42.73 -0.49 (-1.13%)
Earnings Announcements

Vaxcyte Reports Third Quarter 2022 Financial Results And Provides Business Update

Published: 11/07/2022 22:35 GMT
Vaxcyte Inc (PCVX) - Vaxcyte Reports Third Quarter 2022 Financial Results and Provides Business Update.
Vaxcyte Inc Qtrly Loss per Share $0.93.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.82

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.76

More details on our Analysts Page.